Get the Stockscreener App
2.17
11.52%
-0.26
After Hours:
2.24
0.07
+3.23%
Kala Bio Inc stock is traded at $2.17, with a volume of 132.04K.
It is down -11.52% in the last 24 hours and down -68.41% over the past month.
Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
See More
Previous Close:
$2.43
Open:
$2.43
24h Volume:
132.04K
Relative Volume:
0.83
Market Cap:
$40.25M
Revenue:
$420.00K
Net Income/Loss:
$-26.98M
P/E Ratio:
-0.5201
EPS:
-4.1721
Net Cash Flow:
$-32.01M
1W Performance:
-15.02%
1M Performance:
-68.41%
6M Performance:
-95.28%
1Y Performance:
-98.94%
1-Day Range:
$2.10
$2.43
1-Week Range:
$2.10
$2.88
52-Week Range:
$2.10
$1,030.00
Kala Bio Inc Stock (KALA) Company Profile
Name
Kala Bio Inc
Sector
Industry
Phone
781-996-5252
Address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA
Compare KALA vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
2.165 | 45.17M | 420.00K | -26.98M | -32.01M | -4.1721 |
VRTX
Vertex Pharmaceuticals Inc
|
435.92 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.42 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.61 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-30-25 | Downgrade | Mizuho | Outperform → Neutral |
| Sep-29-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-29-25 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-08-25 | Initiated | Mizuho | Outperform |
| Jul-11-25 | Initiated | Ladenburg Thalmann | Buy |
| Mar-30-22 | Downgrade | JP Morgan | Neutral → Underweight |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-14-20 | Downgrade | Jefferies | Buy → Hold |
| Jul-23-20 | Initiated | Northland Capital | Outperform |
| Jun-01-20 | Resumed | Oppenheimer | Outperform |
| May-27-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-17-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-14-19 | Initiated | Jefferies | Buy |
View All
Kala Bio Inc Stock (KALA) Latest News
KALA Should I Buy - Intellectia AI
Kala Bio (FRA:27F) Cyclically Adjusted Price-to-FCF : (As of May. 17, 2026) - GuruFocus
Red Light Holland Corp (OP: TRUFF - FinancialContent
KALA stock hits record low – firm announces reverse split after shares fail to surpass the $1 mark - MSN
KALA BIO (KALA) files 13G/A: Baker Bros. reports 2,312 shares post-split - Stock Titan
KALA BIO, Inc. 1Q 2026: Net loss $(1.6M), Diluted EPS $(0.14) — 10-Q Summary - TradingView
KALA BIO: Q1 Earnings Snapshot - kare11.com
KALA: Q1 2026 net loss fell to $1.6M as focus shifted to AI platform and cost reductions - TradingView
KALA BIO, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
KALA BIO (NASDAQ: KALA) slashes R&D spend and pivots to Researgency AI platform - Stock Titan
Exclusive: Penny stock Kala Bio transitions to revenue model with AI platform launch - MSN
Total assets of KALA BIO, Inc. – LSX:A4243T - TradingView
Discontinued operations of KALA BIO, Inc. – TRADEGATE:27F - TradingView
Cash from operating activities of KALA BIO, Inc. – FWB:27F - TradingView
Asset turnover of KALA BIO, Inc. – FWB:27F - TradingView
Working capital per share of KALA BIO, Inc. – FWB:27F - TradingView
Price to book ratio of KALA BIO, Inc. – FWB:27F - TradingView
KALA BIO, Inc. Balance Sheet – TRADEGATE:27F - TradingView
Discontinued operations of KALA BIO, Inc. – LSX:A4243T - TradingView
Dilution adjustment of KALA BIO, Inc. – GETTEX:27F - TradingView
KALA BIO, Inc. Balance Sheet – LS:A4243T - TradingView
KALA BIO, Inc. Balance Sheet – GETTEX:27F - TradingView
Discontinued operations of KALA BIO, Inc. – FWB:27F - TradingView
Enterprise value to EBITDA ratio of KALA BIO, Inc. – FWB:27F - TradingView
KALA BIO, Inc. Earnings and Revenue – MUN:27F - TradingView
Why Kala Bio’s Stock Is Sinking Again - TipRanks
CapEx per share of KALA BIO INC. O.N. – MUN:27F - TradingView
EBIT per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Free cash flow per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Long term debt to total equity ratio of KALA BIO INC. O.N. – MUN:27F - TradingView
Tangible book value per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Debt to equity ratio of KALA BIO INC. O.N. – MUN:27F - TradingView
EBITDA margin % of KALA BIO INC. O.N. – MUN:27F - TradingView
Net current asset value per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Total debt per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Inventory turnover of KALA BIO INC. O.N. – MUN:27F - TradingView
Operating cash flow per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Cash per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Working capital per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Revenue per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Price to cash flow ratio of KALA BIO INC. O.N. – MUN:27F - TradingView
EBITDA per share of KALA BIO INC. O.N. – MUN:27F - TradingView
Gross margin % of KALA BIO INC. O.N. – MUN:27F - TradingView
Cost of goods sold of KALA BIO INC. O.N. – MUN:27F - TradingView
Non-controlling/minority interest of KALA BIO INC. O.N. – MUN:27F - TradingView
Diluted earnings per share (diluted EPS) of KALA BIO INC. O.N. – MUN:27F - TradingView
Average basic shares outstanding of KALA BIO INC. O.N. – MUN:27F - TradingView
Taxes of KALA BIO INC. O.N. – MUN:27F - TradingView
Diluted shares outstanding of KALA BIO INC. O.N. – MUN:27F - TradingView
Discontinued operations of KALA BIO INC. O.N. – MUN:27F - TradingView
Diluted net income available to common stockholders of KALA BIO INC. O.N. – MUN:27F - TradingView
Kala Bio Inc Stock (KALA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.49%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):